Dr. Peter Gottlieb, MD
Claim this profileUniversity of Colorado School of Medicine: Barbara Davis Center for Diabetes
Area of expertise
Type 1 Diabetes
Peter Gottlieb, MD has run 4 trials for Type 1 Diabetes. Some of their research focus areas include:
Diabetes
Peter Gottlieb, MD has run 4 trials for Diabetes. Some of their research focus areas include:
Affiliated Hospitals
University Of Colorado School Of Medicine: Barbara Davis Center For Diabetes
University Of Colorado, Denver
Clinical Trials Peter Gottlieb, MD is currently running
MAS-1 Adjuvanted Immunotherapy
for Type 1 Diabetes
This trial tests a new vaccine mixed with a booster substance to help patients with type 1 diabetes. The goal is to retrain their immune system to stop attacking insulin-producing cells, potentially improving their condition.
Recruiting
1 award
Phase 1
9 criteria
Observational Study
for Type 1 Diabetes
This is a multi-center, prospective, non-interventional study that focuses on the long- term effects following participation in selected ITN new-onset Type1 Diabetes Mellitus studies with immunomodulatory agents (T1DM, T1D). This observational study will: * follow participants to determine how long they continue to produce insulin, and * will also assess how changes in the immune system over time relate to the ability to produce insulin. This information could help design better therapies for type 1 diabetes in the future.
Recruiting
1 award
N/A
2 criteria
More about Peter Gottlieb, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Peter Gottlieb, MD has experience with
- MAS-1 Adjuvanted Insulin B-chain
- Siplizumab
- Abatacept
- Rituximab
Breakdown of trials Peter Gottlieb, MD has run
Type 1 Diabetes
Diabetes
Insulin Resistance
Impaired Glucose Tolerance
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peter Gottlieb, MD specialize in?
Peter Gottlieb, MD focuses on Type 1 Diabetes and Diabetes. In particular, much of their work with Type 1 Diabetes has involved ZnT8 positive patients, or patients who are GAD-65 positive.
Is Peter Gottlieb, MD currently recruiting for clinical trials?
Yes, Peter Gottlieb, MD is currently recruiting for 2 clinical trials in Aurora Colorado. If you're interested in participating, you should apply.
Are there any treatments that Peter Gottlieb, MD has studied deeply?
Yes, Peter Gottlieb, MD has studied treatments such as MAS-1 adjuvanted Insulin B-chain, Siplizumab, Abatacept.
What is the best way to schedule an appointment with Peter Gottlieb, MD?
Apply for one of the trials that Peter Gottlieb, MD is conducting.
What is the office address of Peter Gottlieb, MD?
The office of Peter Gottlieb, MD is located at: University of Colorado School of Medicine: Barbara Davis Center for Diabetes, Aurora, Colorado 80045 United States. This is the address for their practice at the University of Colorado School of Medicine: Barbara Davis Center for Diabetes.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.